Grace Therapeutics Reports Financial Results (Press Release Aug 13, 2026)

What Happened

• Grace Therapeutics, Inc. (GRCE) furnished an Item 2.02 Form 8-K on August 13, 2026 reporting results of operations and financial condition. The company attached a press release dated August 13, 2026 as Exhibit 99.1 that contains the announced financial information. The filing also includes the Inline XBRL cover page (Exhibit 104).

Key Details

• Filing date: August 13, 2026 (Form 8-K, Items 2.02 and 9.01).
• Disclosure type: Results of operations and financial condition were furnished (Exhibit 99.1 — press release).
• Technical exhibit: Exhibit 104 is the Cover Page Interactive Data File (Inline XBRL).
• The disclosure was furnished to the SEC (standard distinction: furnished items are provided to the SEC and are generally not "filed" for certain liability provisions).

Why It Matters

• This 8-K indicates Grace Therapeutics has publicly released its latest financial results; investors should read the attached press release (Exhibit 99.1) for specific figures such as revenue, net income/loss, cash balance, and any management commentary or guidance.
• The furnished press release is the primary source for concrete quarterly/period results — review it and any subsequent SEC filings (e.g., Form 10-Q) for more detailed financial statements and analysis before making investment decisions.